In a 26-0 vote, the Senate Finance Committee Nov. 8 reported the Better Mental Health Care, Lower-Cost Drugs, and Extenders Act, bipartisan legislation that includes AHA-supported provisions to improve access to behavioral health care and delay Medicaid disproportionate share hospital reductions.

The AHA-supported provisions would provide Medicare incentives to integrate behavioral health and primary care; delay certain Medicaid disproportionate share hospital payment reductions for two years; and permanently grant state Medicaid programs the option to receive federal matching payments for substance use disorder treatment provided in certain institutions for mental diseases. The legislation also would ensure timely communication regarding telehealth and interstate licensure requirements, and extend certain Medicare payment provisions for physicians and clinical laboratory services.

Headline
The Substance Abuse and Mental Health Services Administration has released an advisory examining innovative solutions to close gaps in behavioral health care…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
America’s hospitals and health systems are deeply committed to providing high-quality, accessible and affordable care, AHA President and CEO Rick Pollack March…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
Jeremy Fish, M.D., director of the Family Medicine Residency Program at John Muir Health, and Pilar Corcoran-Lozano, behavioral health corps faculty and…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…